Cargando…

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction

BACKGROUND: The aim of this study is to develop a prognostic nomogram for patients with adenocarcinoma of esophagogastric junction and compare its predictive accuracy with the traditional tumor-node-metastasis (TNM) malignant staging system. METHODS: Patients from the Surveillance, Epidemiology, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhangjian, Zhang, Hao, Xu, Zisen, Li, Wenhan, Dang, Chengxue, Song, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465317/ https://www.ncbi.nlm.nih.gov/pubmed/26055624 http://dx.doi.org/10.1186/s12957-015-0613-7

Ejemplares similares

Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
por: Zhang, Hao, et al.
Publicado: (2013)

The Management and Prognostic Prediction of Adenocarcinoma of Appendix
por: Xie, Xin, et al.
Publicado: (2016)

Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum
por: Xie, Xin, et al.
Publicado: (2017)

Ratio of Metastatic to Examined Lymph Nodes, a Helpful Staging System and Independent Prognostic Factor of Esophagogastric Junction Cancer
por: Zhang, Hao, et al.
Publicado: (2013)

Mist1 Inhibits Epithelial-Mesenchymal Transition in Gastric Adenocarcinoma via Downregulating the Wnt/β-catenin Pathway
por: Xie, Xin, et al.
Publicado: (2021)

Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation
por: Liu, Feng, et al.
Publicado: (2019)

Relationships between p14(ARF) Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis
por: Zhou, Zhangjian, et al.
Publicado: (2016)

Nomogram predicted risk of peripherally inserted central catheter related thrombosis
por: Hao, Nan, et al.
Publicado: (2017)

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery
por: Guo, Zhenjiang, et al.
Publicado: (2022)

Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data
por: Chen, Jian, et al.
Publicado: (2021)

Itraconazole inhibits the proliferation of gastric cancer cells in vitro and improves patient survival
por: Lan, Ke, et al.
Publicado: (2018)

A novel nomogram based on clinical blood indicators for prognosis prediction in curatively resected esophagogastric junction adenocarcinoma patients
por: Liu, Can-Tong, et al.
Publicado: (2023)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer
por: Diao, Dongmei, et al.
Publicado: (2017)

Differences between carcinoma of the cecum and ascending colon: Evidence based on clinical and embryological data
por: Xie, Xin, et al.
Publicado: (2018)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Treatment strategies and predicting prognoses in elderly patients with breast cancer
por: Wang, Zhi, et al.
Publicado: (2018)

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
por: Wang, Shuxing, et al.
Publicado: (2021)

Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction
por: Han, Wen-xiu, et al.
Publicado: (2016)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
por: Li, Haijun, et al.
Publicado: (2017)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
por: Xu, Haitao, et al.
Publicado: (2020)

Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study
por: Liu, Xin, et al.
Publicado: (2021)

Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2018)

Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
por: Nobel, Tamar, et al.
Publicado: (2019)

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
por: Laxague, Francisco, et al.
Publicado: (2021)

Esophagogastric junctional neuroendocrine tumor with adenocarcinoma: A case report
por: Kong, Zhen-Zhen, et al.
Publicado: (2022)

A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma
por: Kang, Huafeng, et al.
Publicado: (2020)

The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
por: Li, Zheng, et al.
Publicado: (2021)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review
por: Cao, Fei, et al.
Publicado: (2022)

Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction
por: Wei, Zhi-Jian, et al.
Publicado: (2022)

Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
por: Nagami, Yasuaki, et al.
Publicado: (2014)

Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?
por: Sato, Yuya, et al.
Publicado: (2018)

MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
por: Just, Christina, et al.
Publicado: (2019)

Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
por: Tang, Weifeng, et al.
Publicado: (2019)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
por: Pang, Tao, et al.
Publicado: (2023)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g62mqvia0tfekljm3mgbsvdssb